About
Bart De Strooper is a Belgian neuroscientist and dementia researcher known for major work on Alzheimer's disease mechanisms, including presenilin/gamma-secretase and ADAM10. He was the founding director of the UK Dementia Research Institute from 2016 to 2023 and is now a group leader there, while also holding professorial roles at UCL, KU Leuven, and VIB. He also helped create K5 Therapeutics, which later joined with Muna Therapeutics in neurodegeneration drug discovery.
Areas of interest
neurosciencedementiaAlzheimer's diseaseParkinson's diseaseneurodegenerationdrug discoverybiotechhealthy agingtranslational medicine